Investors Snatch STOK Even Lower Than Its Secondary Stock Offering
July 01, 2024 at 12:45 PM EDT
Looking back to 96 days ago, Stoke Therapeutics Inc (STOK) priced a 9,259,287 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..